You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

US Patent Family Members and Approved Drugs for United States of America Patent: 2025145698

✉ Email this page to a colleague

« Back to Dashboard

US Patent Family Members and Approved Drugs for United States of America Patent: US2025145698

These international patent data are derived from patent families, based on US drug-patent linkages. Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.

Subscribe to access the full database, or Get Started Free
US Patent Number	Estimated Patent Expiration	Generic Name	US Applicant	US Tradename
10,227,400	2034-03-07	ravulizumab-cwvz	Alexion Pharmaceuticals, Inc.	ULTOMIRIS
10,584,164	2044-05-16	ravulizumab-cwvz	Alexion Pharmaceuticals, Inc.	ULTOMIRIS
9,079,949	2034-03-07	ravulizumab-cwvz	Alexion Pharmaceuticals, Inc.	ULTOMIRIS
9,107,861	2034-03-07	ravulizumab-cwvz	Alexion Pharmaceuticals, Inc.	ULTOMIRIS
9,206,251	2034-03-07	ravulizumab-cwvz	Alexion Pharmaceuticals, Inc.	ULTOMIRIS
9,371,377	2034-03-07	ravulizumab-cwvz	Alexion Pharmaceuticals, Inc.	ULTOMIRIS
9,663,574	2034-03-07	ravulizumab-cwvz	Alexion Pharmaceuticals, Inc.	ULTOMIRIS
>US Patent Number	>Estimated Patent Expiration	>Generic Name	>US Applicant	>US Tradename

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.